ABCL logo

AbCellera Biologics Inc. Common Shares


ABCL: AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the most effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.


Show ABCL Financials

Consumer Interest
SEC Filings

Recent trades of ABCL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ABCL's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases


Number of mentions of ABCL in WallStreetBets Daily Discussion


Recent insights relating to ABCL

CNBC Recommendations

Recent picks made for ABCL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ABCL

Corporate Flights

Flights by private jets registered to ABCL